For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Search Posts
Blog
A typology for risk assessment?
New research may help to explain why the term “risk” shouldn’t automatically be applied to new technologies, such as biotechnology. According to…
Op-Eds
Lance Armstrong’s Self-Inflicted Cancer?
Did the use of performance-enhancing drugs cause seven-time Tour de France winner Lance Armstrong’s testicular cancer? That’s what a Sports Illustrated columnist suggested this…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH The Food and Drug Administration approves the first fully implantable artificial heart.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY President Bush makes access to affordable energy the focus of his Labor Day…
Op-Eds
Why spurning food biotech has become a liability
Henry I. Miller, MD, Gregory Conko & Drew L. Kershen By rejecting gene-spliced ingredients in their products, some major food companies may be…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HURRICANE KATRINA A recent survey of Hurricane Katrina survivors finds a renewed sense of…